The FDA has scheduled an Oct. 15 meeting of its advisory committee to discuss whether to grant authorization for a booster dose of the J&J vaccine.
Related Articles
-
Unexplained Covid cases prompt first lockdown in New Zealand since August
WELLINGTON, New Zealand — New Zealand’s largest city of Auckland will go into a three-day lockdown beginning just before...
-
‘A black eye for the CDC’: Director walks back coronavirus testing guidance
The federal government appears to have backtracked on COVID-19 testing guidance, according to a statement released late Wednesday from...
-
Pediatric brain tumors are rare but serious conditions in infants, doctor says
The 5-month-old son of celebrity Nick Cannon died recently of a brain tumor, a rare but a serious condition...
-
Younger Latino men are Covid’s biggest victims as families grapple with loss
Melanie Hoyos, 22, recently received news that she had landed a job as an animal technician. But the first...
-
‘I don’t know of a time that’s worse than this’: Cancer drug shortages grow more acute
Widespread shortages of cancer drugs are forcing doctors to make difficult decisions about how to treat their patients, including...
-
More free Covid tests will be available in late September, Biden admin says
Free Covid-19 tests will be available once again come late September, the Biden administration announced Friday. “These tests will...
-
Weight loss drugs may be up for Medicare price negotiations
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden...
-
4th case of bird flu linked to dairy cows detected in Colorado
A fourth person has tested positive for bird flu in the outbreak linked to dairy cows, this time in...
Recent Comments